Pharmaceuticals and healthcare

Taylor Wessing takes legal duties for Pfizer in vaccine rollout

Taylor Wessing is advising pharma giant Pfizer on aspects around the rollout of its Covid-19 vaccine across Europe, The Lawyer understands. The firm is understood to be counselling the company on patent issues arising from the unprecedentedly large-scale distribution of the vaccine it developed in conjunction with German biotech company BioNTech. It is understood that […]


Freshfields, Macfarlanes and Wachtell lead on AstraZeneca’s mega-pharma deal

Freshfields Bruckhaus Deringer, Macfarlanes and Wachtell Lipton Rosen & Katz have spearheaded AstraZeneca’s $39bn (£29.5bn) stock-and-cash acquisition of US biotech Alexion. Cambridge-headquartered AstraZeneca’s acquisition of its US rival comes amid its central role in developing the much-anticipated Covid-19 vaccine with the University of Oxford. Freshfields advised AstraZeneca on both the US and UK legal aspects […]

NHS health

DWF wins NHS Digital Covid-19 mandate

DWF has won a mandate to provide Covid-19 legal advice to NHS Digital, the information and technology provider for the national healthcare system. A team from the listed firm will be seconded to the public body as part of a £227,000 contract. The team seconded includes Manchester data protection head and partner JP Buckley and […]


Supreme Court setback in Sidley’s competition battle for Servier

The Supreme Court has dismissed Sidley Austin’s drug patent appeal, in a dispute between a French pharma company and the NHS. The US firm has been representing French headquartered Servier Laboratories in its dispute with The Secretary of State for Health and the NHS, which instructed Peters & Peters. It was alleged that Servier breached […]


Teva narrows down firms for global legal panel

Teva is close to finalising its global legal panel, following a tender process lasting over a year and a half. Pinsent Masons, Goodwin Procter and Taylor Wessing are understood to be among the contenders vying for a place on the pharmaceutical giant’s latest panel. A source told The Lawyer that Teva has not specified how […]

Bjarne Tellmann pearson

FTSE 100 giant Pearson loses GC to GSK

Pearson’s general counsel is leaving the education publisher to join GlaxoSmithKline’s consumer healthcare business. Bjarne Tellmann – who has been Pearson’s GC for six years – is joining GSK where he will take up the role of senior vice president and general counsel from July. Tellmann joined Pearson in 2014 from the Coca-Cola company, where […]


Mills & Reeve triumphs for NHS in scrap over pharma drug

In a decision that could potentially save the NHS up to £500m a year, Mills & Reeve and Landmark Chambers yesterday secured a monumental Court of Appeal victory over Arnold & Porter and Covington & Burling, duly defeating two big pharma companies in the process. The contentious rematch saw both Bayer and Novartis fail to […]

Coronovirus in the workplace

US and European firms lead on $11.5bn purchase of disease test kit maker

Wachtell Lipton Rosen & Katz, De Brauw Blackstone Westbroek, Linklaters and Hengeler Mueller all picked up roles on the $11.5bn acquisition of a German pharmaceutical testing company by a US scientific instruments maker. Wachtell, Hengeler and Dutch firm NautaDutilh acted for Thermo Fisher, which yesterday bought the testing company Qiagen, advised by De Brauw, Linklaters […]